Cargando…

PARP-1 inhibition with or without ionizing radiation confers reactive oxygen species-mediated cytotoxicity preferentially to cancer cells with mutant TP53

Biomarkers and mechanisms of poly (ADP-ribose) polymerase (PARP) inhibitor-mediated cytotoxicity in tumor cells lacking a BRCA-mutant or BRCA-like phenotype are poorly defined. We sought to explore the utility of PARP-1 inhibitor (PARPi) treatment with/without ionizing radiation in muscle-invasive b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Qi, Gheorghiu, Liliana, Drumm, Michael, Clayman, Rebecca, Eidelman, Alec, Wszolek, Matthew F., Olumi, Aria, Feldman, Adam, Wang, Meng, Marcar, Lynnette, Citrin, Deborah E., Wu, Chin-Lee, Benes, Cyril H., Efstathiou, Jason A., Willers, Henning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5970015/ https://www.ncbi.nlm.nih.gov/pubmed/29511347 http://dx.doi.org/10.1038/s41388-018-0130-6

Ejemplares similares

Acquired Resistance of EGFR-Mutated Lung Cancer to Tyrosine Kinase Inhibitor Treatment Promotes PARP Inhibitor Sensitivity
por: Marcar, Lynnette, et al.
Publicado: (2019)

TP53 mutation status: emerging biomarker for precision radiation medicine?
por: Willers, Henning, et al.
Publicado: (2018)

Self-Retraction Clamp for Dissection of the Posterior Prostatic Fossa During Radical Retropubic Prostatectomy
por: Olumi, Aria F.
Publicado: (2004)

Preferential potentiation of topoisomerase I poison cytotoxicity by PARP inhibition in S phase
por: Znojek, P, et al.
Publicado: (2014)

Combinations of PARP Inhibitors with Temozolomide Drive PARP1 Trapping and Apoptosis in Ewing’s Sarcoma
por: Gill, Sonja J., et al.
Publicado: (2015)

PARP Inhibitors Talazoparib and Niraparib Sensitize Melanoma Cells to Ionizing Radiation
por: Jonuscheit, Stephanie, et al.
Publicado: (2021)

BRCA1 and TP53 codeficiency causes a PARP inhibitor–sensitive erythroproliferative neoplasm
por: Lopez-Perez, Gerardo, et al.
Publicado: (2022)

Ionizing Radiation-Induced Responses in Human Cells with Differing TP53 Status
por: Mirzayans, Razmik, et al.
Publicado: (2013)

Nitric oxide-donor/PARP-inhibitor combination: A new approach for sensitization to ionizing radiation
por: Wilson, Aaron, et al.
Publicado: (2019)

PARP inhibitors combined with ionizing radiation induce different effects in melanoma cells and healthy fibroblasts
por: Weigert, Verena, et al.
Publicado: (2020)

Molecular Characterization of TP53 Gene in Human Populations Exposed to Low-Dose Ionizing Radiation
por: Brasil-Costa, Igor, et al.
Publicado: (2013)

Growth of pancreatic cancers with hemizygous chromosomal 17p loss of MYBBP1A can be preferentially targeted by PARP inhibitors
por: Hsieh, Antony, et al.
Publicado: (2020)

CAF-1 Subunits Levels Suggest Combined Treatments with PARP-Inhibitors and Ionizing Radiation in Advanced HNSCC
por: Morra, Francesco, et al.
Publicado: (2019)

Activation of AKR1C1/ERβ induces apoptosis by downregulation of c-FLIP in prostate cancer cells: A prospective therapeutic opportunity
por: Yun, Huiyoung, et al.
Publicado: (2015)

The effect of serum starvation on tight junctional proteins and barrier formation in Caco-2 cells
por: Ross, Aisling M., et al.
Publicado: (2021)

Ionizing radiation-induced NF-κB activation requires PARP-1 function to confer radio-resistance
por: Veuger, Stephany J., et al.
Publicado: (2008)

Association between PSCA, TNF-α, PARP1 and TP53 Gene Polymorphisms and Gastric Cancer Susceptibility in the Brazilian Population
por: Dantas, Roberto Nery, et al.
Publicado: (2020)

Preferential Packing of Acidic Glycosidases and Proteases into Bacteroides Outer Membrane Vesicles
por: Elhenawy, Wael, et al.
Publicado: (2014)

Reduced PARP1 as a Serum Biomarker for Graft Rejection in Kidney Transplantation
por: Srivastava, Meera, et al.
Publicado: (2015)

Identification of Nanoparticle Properties for Optimal Drug Delivery across a Physiological Cell Barrier
por: Ross, Aisling M., et al.
Publicado: (2023)

Immunomodulatory Roles of PARP-1 and PARP-2: Impact on PARP-Centered Cancer Therapies
por: Yélamos, José, et al.
Publicado: (2020)

PARP Power: A Structural Perspective on PARP1, PARP2, and PARP3 in DNA Damage Repair and Nucleosome Remodelling
por: van Beek, Lotte, et al.
Publicado: (2021)

Metformin inhibits the proliferation of benign prostatic epithelial cells
por: Wang, Zongwei, et al.
Publicado: (2017)

Effects of Combined Treatment with Ionizing Radiation and the PARP Inhibitor Olaparib in BRCA Mutant and Wild Type Patient-Derived Pancreatic Cancer Xenografts
por: Lohse, Ines, et al.
Publicado: (2016)

PARP inhibitors trap PARP2 and alter the mode of recruitment of PARP2 at DNA damage sites
por: Lin, Xiaohui, et al.
Publicado: (2022)

PARP inhibitors
por: Anwar, Maheen, et al.
Publicado: (2015)

Are PARPs promiscuous?
por: Feijs, Karla L.H., et al.
Publicado: (2022)

Preferential Cochleotoxicity of Cisplatin
por: Prayuenyong, Pattarawadee, et al.
Publicado: (2021)

PARP1 in Carcinomas and PARP1 Inhibitors as Antineoplastic Drugs
por: Wang, Luyao, et al.
Publicado: (2017)

Interactions of PARP1 Inhibitors with PARP1-Nucleosome Complexes
por: Maluchenko, Natalya, et al.
Publicado: (2022)

Molecular correlates of sensitivity to PARP inhibition beyond homologous recombination deficiency in pre-clinical models of colorectal cancer point to wild-type TP53 activity
por: Smeby, Jørgen, et al.
Publicado: (2020)

Wound trauma alters ionizing radiation dose assessment
por: Kiang, Juliann G, et al.
Publicado: (2012)

Assessment of Tp–e interval, Tp–e/QT, and Tp-e/QTc ratios in patients with acromegaly
por: ÇELİK, İbrahim Etem, et al.
Publicado: (2022)

Distinct roles of XRCC4 and Ku80 in non-homologous end-joining of endonuclease- and ionizing radiation-induced DNA double-strand breaks
por: Schulte-Uentrop, Leonie, et al.
Publicado: (2008)

Mono-ADP-ribosylation by PARP10 and PARP14 in genome stability
por: Dhoonmoon, Ashna, et al.
Publicado: (2023)

Clinical PARP inhibitors allosterically induce PARP2 retention on DNA
por: Langelier, Marie-France, et al.
Publicado: (2023)

To see or not to see; the ability of the magno‐ and parvocellular response to manifest itself in the VEP determines its appearance to a pattern reversing and pattern onset stimulus
por: Marcar, Valentine L., et al.
Publicado: (2016)

Neural response during temporal – and spatial luminance contrast processing and its manifestation in the blood-oxygen-level-dependent-signal in striate and extra-striate cortex
por: Marcar, Valentine L., et al.
Publicado: (2021)

ATR inhibition disrupts rewired homologous recombination and fork protection pathways in PARP inhibitor-resistant BRCA-deficient cancer cells
por: Yazinski, Stephanie A., et al.
Publicado: (2017)

Alginate-based 3D cancer cell culture for therapeutic response modeling
por: Davoudi, Farideh, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4h253qblv4a1h5ds1v8or0cb4u